Loading clinical trials...
Loading clinical trials...
Phase II Study of De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal Squamous Cell Carcinoma
Conditions
Interventions
Intensity Modulated Radiotherapy (IMRT)
Cisplatin
+1 more
Locations
5
United States
Penrose Cancer Center
Colorado Springs, Colorado, United States
University of Florida, Department of Radiation Oncology
Gainesville, Florida, United States
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Chapel Hill, North Carolina, United States
Rex Healthcare
Raleigh, North Carolina, United States
Rex Cancer Center of Wakefield
Raleigh, North Carolina, United States
Start Date
February 7, 2012
Primary Completion Date
November 1, 2014
Completion Date
November 1, 2019
Last Updated
November 13, 2024
NCT04099290
NCT06998069
NCT06912087
NCT06303180
NCT07158164
NCT04429542
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions